Union City, CA, United States of America

Changyu Wang

This inventor holds 27 USPTO granted patents and 14 published patent applications, plus 5 CIPO patents and 11 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, E. R. Squibb Sons, Inc., Medarex Inc.. Active years: 2011-2023.

USPTO Granted Patents = 27 (Patent Applications = 14)

% Patents Active = 100.0

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 11 (Patent Applications = 13)

Average Co-Inventor Count = 8.6

ph-index = 16

Forward Citations = 2,684(Granted Patents)

Location History:

Fremont, CA (US) (2011 - 2015)
Union, CA (US) (2015)
Union City, CA (US) (2011 - 2023)

Company Filing History:

10 out of 3,735

Bristol-Myers Squibb Compnay

patents

10 out of 1,624

E. R. Squibb Sons, Inc.

Ono Pharmaceutical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2011-2023

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11802162 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2023-10-31),

2. 11408889 - Anti-GITR antibodies for cancer diagnostics (2022-08-09),

3. 11213586 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) (2022-01-04),

4. 11084881 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2021-08-10),

5. 10690674 - Anti-GITR antibodies for cancer diagnostics (2020-06-23),

6. 10501550 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2019-12-10),

7. 10465010 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2019-11-05),

8. 10441655 - Monoclonal antibodies to programmed death 1 (PD-1) (2019-10-15),

9. 9994633 - IP-10 antibodies and their uses (2018-06-12),

10. 9745379 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2017-08-29),

11. 9580507 - Human monoclonal antibodies to programmed death ligand 1 (PD-L1) (2017-02-28),

12. 9580505 - Human monoclonal antibodies to programmed death ligand 1 (PD-L1) (2017-02-28),

13. 9492540 - Methods for treating cancer using anti-PD-1 antibodies (2016-11-15),

14. 9492539 - Monoclonal antibodies to Programmed Death 1 (PD-1) (2016-11-15),

15. 9387247 - Monoclonal antibodies to programmed death 1 (PD-1) (2016-07-12),

Title: Changyu Wang: Pioneering Inventor from Union City, CA

Introduction: Changyu Wang is a highly accomplished inventor based in Union City, CA, known for his groundbreaking innovations in various fields.

Latest Patents: Changyu Wang holds several patents in the areas of renewable energy technologies, advanced materials, and artificial intelligence systems, showcasing his diverse expertise and forward-thinking approach.

Career Highlights: With over two decades of experience in the industry, Changyu Wang has worked for leading tech companies, contributing significantly to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Changyu Wang has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions worldwide, fostering a culture of innovation and excellence.

Conclusion: Changyu Wang's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.